Table. 1 Baseline characteristics of the SA-AKI cohort
Baseline characteristics | Non_AKI (n = 44) | AKI (n = 70) | p-value |
|---|---|---|---|
Age (year) | 74.000 (64.000–83.000) | 74.500 (60.000–80.250) | 0.724 |
Max_Scr (mg/dl) | 0.705 (0.525–0.885) | 1.933 (1.530–2.589) | 3.0E−15 |
Min_eGFR (mL/min/1.73 m2) | 94.988 (82.375–115.438) | 30.044 (23.053–40.684) | 1.0E−15 |
Procalcitonin (ng/ml) | 0.280 (0.101–1.540) | 8.180 (1.208–30.000) | 4.3E−9 |
HCRP (mg/L) | 57.430 (20.328–91.683) | 114.380 (60.850–201.825) | 3.0E−4 |
Urine (ml/24 h) | 1800.000 (1490.000–2150.000) | 1080.000 (798.000–1460.000) | 2.1E−7 |
Hemoglobin (g/L) | 109.500 (98.500–119.250) | 103.500 (89.000–124.000) | 0.412 |
SOFA | 10.000 (8.000–12.000) | 11.000 (9.000–13.000) | 0.025 |
Gender (%) | 0.892 | ||
Male | 29 (65.91%) | 47 (67.14%) | |
Female | 15 (34.09%) | 23 (32.86%) | |
AKI stage (%) | 1.0E−15 | ||
0 | 44 (100%) | – | |
1 | – | 29 (41.4%) | |
2 | – | 31 (44.3%) | |
3 | – | 10 (14.3%) | |
Hypertension (%) | 0.86 | ||
No | 24 (54.55%) | 37 (52.86%) | |
Yes | 20 (45.45%) | 33 (47.14%) | |
Diabetes (%) | 0.637 | ||
No | 27 (61.36%) | 46 (65.71%) | |
Yes | 17 (38.64%) | 24 (34.29%) | |
Smoking (%) | 0.755 | ||
No | 32 (72.73%) | 49 (70.00%) | |
Yes | 12 (27.27%) | 21 (30.00%) | |
Cardiovascular diseases (%) | 0.753 | ||
No | 27 (61.36%) | 45 (64.29%) | |
Yes | 17 (38.64%) | 25 (35.71%) | |
Mechanical. Ventilation (%) | 0.057 | ||
No | 25 (56.82%) | 27 (38.57%) | |
Yes | 19 (43.18%) | 43 (61.43%) | |
Catecholamines (%) | 0.021 | ||
No | 22 (50.00%) | 20 (28.57%) | |
Yes | 22 (50.00%) | 50 (71.43%) | |
Source.of.infection (%) | 0.037 | ||
Bacteria | 18 (40.91%) | 36 (51.43%) | |
Virus | 1 (2.27%) | 9 (12.86%) | |
Fungus | 9 (20.45%) | 5 (7.14%) | |
Undetected | 16 (36.36%) | 20 (28.57%) |
